Publications by authors named "Takehiro Ura"

Claim this Profile
B
Biodistribution and immunity of adenovirus 5/35 and modified vaccinia Ankara vector vaccines against human immunodeficiency virus 1 clade C.
Masaru Shimada, Haibin Wang, Motohide Ichino, Takehiro Ura, Nobuhisa Mizuki

Gene Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Vaccine Platforms in Enhancing T-Cell Response.
Takehiro Ura, Masaki Takeuchi, Tatsukata Kawagoe, Nobuhisa Mizuki, Kenji Okuda

Vaccines (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic and therapeutic vaccine against Pseudomonas aeruginosa keratitis using bacterial membrane vesicles.
Saori Ito, Jutaro Nakamura, Michiko Fukuta, Takehiro Ura, Takeshi Teshigawara

Vaccine· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
Takehiro Ura, Akio Yamashita, Nobuhisa Mizuki, Kenji Okuda, Masaru Shimada

Vaccine· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy.
Takuwa Yasuda, Takehiro Ura, Masaru Taniguchi, Hisahiro Yoshida

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developments in Viral Vector-Based Vaccines.
Takehiro Ura, Kenji Okuda, Masaru Shimada

Vaccines (Basel)· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5.
Shinya Abe, Kenji Okuda, Takehiro Ura, Asami Kondo, Atsushi Yoshida

J Gene Med· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designed recombinant adenovirus type 5 vector induced envelope-specific CD8(+) cytotoxic T lymphocytes and cross-reactive neutralizing antibodies against human immunodeficiency virus type 1.
Takehiro Ura, Atsushi Yoshida, Ke-Qin Xin, Shinji Yoshizaki, Sayaka Yashima

J Gene Med· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actin network formation by unidirectional polycation diffusion.
Hyuck Joon Kwon, Akira Kakugo, Takehiro Ura, Takaharu Okajima, Yoshimi Tanaka

Langmuir· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis